Detalles de la búsqueda
1.
Genetic and phenotypic characterisation of HIV-associated aggressive B-cell non-Hodgkin lymphomas, which do not occur specifically in this population: diagnostic and prognostic implications.
Histopathology;
81(6): 826-840, 2022 Dec.
Artículo
en Inglés
| MEDLINE | ID: mdl-36109172
2.
Mutations in the RAS-BRAF-MAPK-ERK pathway define a specific subgroup of patients with adverse clinical features and provide new therapeutic options in chronic lymphocytic leukemia.
Haematologica;
104(3): 576-586, 2019 03.
Artículo
en Inglés
| MEDLINE | ID: mdl-30262568
3.
Safety and efficacy of bosutinib in fourth-line therapy of chronic myeloid leukemia patients.
Ann Hematol;
98(2): 321-330, 2019 Feb.
Artículo
en Inglés
| MEDLINE | ID: mdl-30446802
4.
Deleterious Effect of Steroids on Cytomegalovirus Infection Rate after Allogeneic Stem Cell Transplantation Depends on Pretransplant Cytomegalovirus Serostatus of Donors and Recipients.
Biol Blood Marrow Transplant;
24(10): 2088-2093, 2018 10.
Artículo
en Inglés
| MEDLINE | ID: mdl-29753162
5.
Transcriptome characterization by RNA sequencing identifies a major molecular and clinical subdivision in chronic lymphocytic leukemia.
Genome Res;
24(2): 212-26, 2014 Feb.
Artículo
en Inglés
| MEDLINE | ID: mdl-24265505
6.
CD49d (ITGA4) expression is a predictor of time to first treatment in patients with chronic lymphocytic leukaemia and mutated IGHV status.
Br J Haematol;
172(1): 48-55, 2016 Jan.
Artículo
en Inglés
| MEDLINE | ID: mdl-26559905
7.
Clinical effect of driver mutations of JAK2, CALR, or MPL in primary myelofibrosis.
Blood;
124(7): 1062-9, 2014 Aug 14.
Artículo
en Inglés
| MEDLINE | ID: mdl-24986690
8.
Mutations in TLR/MYD88 pathway identify a subset of young chronic lymphocytic leukemia patients with favorable outcome.
Blood;
123(24): 3790-6, 2014 Jun 12.
Artículo
en Inglés
| MEDLINE | ID: mdl-24782504
9.
Prognosis of patients with diffuse large B cell lymphoma not reaching complete response or relapsing after frontline chemotherapy or immunochemotherapy.
Ann Hematol;
94(5): 803-12, 2015 May.
Artículo
en Inglés
| MEDLINE | ID: mdl-25501975
10.
Bosutinib shows low cross intolerance, in chronic myeloid leukemia patients treated in fourth line. Results of the Spanish compassionate use program.
Am J Hematol;
90(5): 429-33, 2015 May.
Artículo
en Inglés
| MEDLINE | ID: mdl-25683327
11.
Chronic lymphocytic leukemia in the elderly: clinico-biological features, outcomes, and proposal of a prognostic model.
Haematologica;
99(10): 1599-604, 2014 Oct.
Artículo
en Inglés
| MEDLINE | ID: mdl-24972773
12.
The prognostic impact of minimal residual disease in patients with chronic lymphocytic leukemia requiring first-line therapy.
Haematologica;
99(5): 873-80, 2014 May.
Artículo
en Inglés
| MEDLINE | ID: mdl-24700492
13.
Relationship between the 46/1 haplotype of the JAK2 gene and the JAK2 mutational status and allele burden, the initial findings, and the survival of patients with myelofibrosis.
Ann Hematol;
93(5): 797-802, 2014 May.
Artículo
en Inglés
| MEDLINE | ID: mdl-24337516
14.
Busulfan in patients with polycythemia vera or essential thrombocythemia refractory or intolerant to hydroxyurea.
Ann Hematol;
93(12): 2037-43, 2014 Dec.
Artículo
en Inglés
| MEDLINE | ID: mdl-24981691
15.
Is there a role for minimal residual disease monitoring in the management of patients with hairy-cell leukaemia?
Br J Haematol;
183(1): 127-129, 2018 10.
Artículo
en Inglés
| MEDLINE | ID: mdl-28832940
16.
Clinical impact of MYD88 mutations in chronic lymphocytic leukemia.
Blood;
127(12): 1611-3, 2016 Mar 24.
Artículo
en Inglés
| MEDLINE | ID: mdl-26847246
17.
Gene-expression profiling and not immunophenotypic algorithms predicts prognosis in patients with diffuse large B-cell lymphoma treated with immunochemotherapy.
Blood;
117(18): 4836-43, 2011 May 05.
Artículo
en Inglés
| MEDLINE | ID: mdl-21441466
18.
Recurrent gene mutations in CLL.
Adv Exp Med Biol;
792: 87-107, 2013.
Artículo
en Inglés
| MEDLINE | ID: mdl-24014293
19.
Improved classification of leukemic B-cell lymphoproliferative disorders using a transcriptional and genetic classifier.
Haematologica;
102(9): e360-e363, 2017 09.
Artículo
en Inglés
| MEDLINE | ID: mdl-28522579
20.
Clinicobiological Characteristics and Outcomes of Patients with T-Cell Large Granular Lymphocytic Leukemia and Chronic Lymphoproliferative Disorder of Natural Killer Cells from a Single Institution.
Cancers (Basel);
13(15)2021 Aug 02.
Artículo
en Inglés
| MEDLINE | ID: mdl-34359799